We welcome back Roivant Sciences with open arms for the continuation of their partnership with BaseLaunch Phase II. Sascha Bucher, Head of Global Transactions at Roivant Sciences, stated “We are proud to continue our partnership with BaseLaunch and support its mission of building companies that deliver innovative medicines to patients.” Neil Goldsmith, Director of Strategy for BaseLaunch, commented “As partners in the first Phase of BaseLaunch, the experience and support of the Roivant team has been invaluable to our portfolio companies.”
Read the full press release here.
